Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1868-1874
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Volume20
Issue number8
DOIs
Publication statusPublished - Aug 2022

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • anticoagulants
  • heparin, low-molecular-weight
  • neoplasms
  • pulmonary embolism
  • venous thrombosis

Fingerprint

Dive into the research topics of 'Step down to 6 months of prophylactic-dose low molecular weight heparin after initial full-dose anticoagulation for the treatment of cancer-associated thrombosis (STEP-CAT): A pilot study'. Together they form a unique fingerprint.

Cite this